
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
<p>Mutational Characterization and Potential Prognostic Biomarkers of Chinese Patients with Esophageal Squamous Cell Carcinoma</p>
Nan Zhang, Junping Shi, Xiaoliang Shi, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 12797-12809
Open Access | Times Cited: 26
Nan Zhang, Junping Shi, Xiaoliang Shi, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 12797-12809
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma
Dominic Wei Ting Yap, Alberto Giovanni Leone, Nicky Zhun Hong Wong, et al.
JAMA Oncology (2022) Vol. 9, Iss. 2, pp. 215-215
Open Access | Times Cited: 50
Dominic Wei Ting Yap, Alberto Giovanni Leone, Nicky Zhun Hong Wong, et al.
JAMA Oncology (2022) Vol. 9, Iss. 2, pp. 215-215
Open Access | Times Cited: 50
Latest insights into the global epidemiological features, screening, early diagnosis and prognosis prediction of esophageal squamous cell carcinoma
Yixin Zhao, Heping Zhao, Mengyao Zhao, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 20, pp. 2638-2656
Open Access | Times Cited: 11
Yixin Zhao, Heping Zhao, Mengyao Zhao, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 20, pp. 2638-2656
Open Access | Times Cited: 11
CDKN2A is a prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
Junpeng Luo, Jing Wang, Jinhua Huang
Bioscience Reports (2021) Vol. 41, Iss. 10
Open Access | Times Cited: 51
Junpeng Luo, Jing Wang, Jinhua Huang
Bioscience Reports (2021) Vol. 41, Iss. 10
Open Access | Times Cited: 51
Shikonin Inhibits Tumor Growth of ESCC by suppressing PKM2 mediated Aerobic Glycolysis and STAT3 Phosphorylation
Qiqi Zhang, Qing Liu, Shutao Zheng, et al.
Journal of Cancer (2021) Vol. 12, Iss. 16, pp. 4830-4840
Open Access | Times Cited: 44
Qiqi Zhang, Qing Liu, Shutao Zheng, et al.
Journal of Cancer (2021) Vol. 12, Iss. 16, pp. 4830-4840
Open Access | Times Cited: 44
TP53 Mutations in Esophageal Squamous Cell Carcinoma
Leqi Zhong, Hongmu Li, Wuguang Chang, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 9
Open Access | Times Cited: 13
Leqi Zhong, Hongmu Li, Wuguang Chang, et al.
Frontiers in Bioscience-Landmark (2023) Vol. 28, Iss. 9
Open Access | Times Cited: 13
New understandings of the pathway of long-chain polyunsaturated fatty acid biosynthesis
J. Thomas Brenna, Kumar S.D. Kothapalli
Current Opinion in Clinical Nutrition & Metabolic Care (2021) Vol. 25, Iss. 2, pp. 60-66
Closed Access | Times Cited: 29
J. Thomas Brenna, Kumar S.D. Kothapalli
Current Opinion in Clinical Nutrition & Metabolic Care (2021) Vol. 25, Iss. 2, pp. 60-66
Closed Access | Times Cited: 29
Novel Immune-Related Ferroptosis Signature in Esophageal Cancer: An Informatics Exploration of Biological Processes Related to the TMEM161B-AS1/hsa-miR-27a-3p/GCH1 Regulatory Network
Min Lu, Jiaqi Li, Xin Fan, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 19
Min Lu, Jiaqi Li, Xin Fan, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 19
Genomic, transcriptomic, and T cell receptor profiling in stratifying response to first-line chemoradiotherapy or radiotherapy for esophageal squamous cell carcinoma
Xiaqin Zhang, Jianhong Lian, Fukun Chen, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Xiaqin Zhang, Jianhong Lian, Fukun Chen, et al.
Frontiers in Oncology (2025) Vol. 14
Open Access
Molecular characteristics and multivariate survival analysis of 43 patients with locally advanced or metastatic esophageal squamous cell carcinoma
Xia Zhou, Wuan Bao, Xiang Zhu, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 3, pp. 1843-1853
Open Access | Times Cited: 3
Xia Zhou, Wuan Bao, Xiang Zhu, et al.
Journal of Thoracic Disease (2024) Vol. 16, Iss. 3, pp. 1843-1853
Open Access | Times Cited: 3
SPOC domain proteins in health and disease
Lisa-Marie Appel, Johannes Benedum, Magdalena Engl, et al.
Genes & Development (2023) Vol. 37, Iss. 5-6, pp. 140-170
Open Access | Times Cited: 8
Lisa-Marie Appel, Johannes Benedum, Magdalena Engl, et al.
Genes & Development (2023) Vol. 37, Iss. 5-6, pp. 140-170
Open Access | Times Cited: 8
Prognostic value of genomic mutation signature associated with immune microenvironment in southern Chinese patients with esophageal squamous cell carcinoma
Yue Zhou, Li Chu, Shuyan Li, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 8
Open Access | Times Cited: 2
Yue Zhou, Li Chu, Shuyan Li, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 8
Open Access | Times Cited: 2
Prognostic biomarkers correlated with immune infiltration in non‐small cell lung cancer
Fei Xu, Wenqiang Cui, Cun Liu, et al.
FEBS Open Bio (2022) Vol. 13, Iss. 1, pp. 72-88
Open Access | Times Cited: 9
Fei Xu, Wenqiang Cui, Cun Liu, et al.
FEBS Open Bio (2022) Vol. 13, Iss. 1, pp. 72-88
Open Access | Times Cited: 9
Clonal relationship and alcohol consumption-associated mutational signature in synchronous hypopharyngeal tumours and oesophageal squamous cell carcinoma
Josephine Mun Yee Ko, Guo Chen, Conghui Liu, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 12, pp. 2166-2174
Open Access | Times Cited: 8
Josephine Mun Yee Ko, Guo Chen, Conghui Liu, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 12, pp. 2166-2174
Open Access | Times Cited: 8
The Cuproptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Immune Cell Infiltration in Hepatocellular Carcinoma
Ying Li, Kaichao Song, Wensheng Zheng
Journal of Oncology (2023) Vol. 2023, pp. 1-22
Open Access | Times Cited: 4
Ying Li, Kaichao Song, Wensheng Zheng
Journal of Oncology (2023) Vol. 2023, pp. 1-22
Open Access | Times Cited: 4
Hippo cooperates with p53 to maintain foregut homeostasis and suppress the malignant transformation of foregut basal progenitor cells
Yu Jiang, Haidi Huang, Jiangying Liu, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 10
Open Access | Times Cited: 1
Yu Jiang, Haidi Huang, Jiangying Liu, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 10
Open Access | Times Cited: 1
Upregulation of Yin-Yang-1 Associates with Proliferation and Glutamine Metabolism in Esophageal Carcinoma
Can Luo, Xin Chen, Yuting Bai, et al.
International Journal of Genomics (2022) Vol. 2022, pp. 1-27
Open Access | Times Cited: 7
Can Luo, Xin Chen, Yuting Bai, et al.
International Journal of Genomics (2022) Vol. 2022, pp. 1-27
Open Access | Times Cited: 7
The effects of altered DNA damage repair genes on mutational processes and immune cell infiltration in esophageal squamous cell carcinoma
Huangbo Yuan, Tao Qing, Sibo Zhu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 8, pp. 10077-10090
Open Access | Times Cited: 3
Huangbo Yuan, Tao Qing, Sibo Zhu, et al.
Cancer Medicine (2023) Vol. 12, Iss. 8, pp. 10077-10090
Open Access | Times Cited: 3
Increased HRD score in cisplatin resistant penile cancer cells
Ria Winkelmann, Katrin Bankov, Claudia Döring, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Ria Winkelmann, Katrin Bankov, Claudia Döring, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Exploiting the Molecular Basis of Oesophageal Cancer for Targeted Therapies and Biomarkers for Drug Response: Guiding Clinical Decision-Making
Sikhumbuzo Z. Mbatha, Rodney Hull, Zodwa Dlamini
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2359-2359
Open Access | Times Cited: 3
Sikhumbuzo Z. Mbatha, Rodney Hull, Zodwa Dlamini
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2359-2359
Open Access | Times Cited: 3
Recent advances in the role of atypical cadherin FAT1 in tumorigenesis (Review)
Tao Wang, Junting Li, Jun Du, et al.
Oncology Letters (2024) Vol. 29, Iss. 3
Open Access
Tao Wang, Junting Li, Jun Du, et al.
Oncology Letters (2024) Vol. 29, Iss. 3
Open Access
Comparative genomic analysis of esophageal squamous cell carcinoma among different geographic regions
Ruixiang Zhang, Canjun Li, Zhiyi Wan, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 1
Ruixiang Zhang, Canjun Li, Zhiyi Wan, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 1
Cohort size required for prognostic genes analysis of stage II/III esophageal squamous cell carcinoma
Linghong Kong, Ming Yang, Zhiyi Wan, et al.
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 1
Linghong Kong, Ming Yang, Zhiyi Wan, et al.
Pathology & Oncology Research (2023) Vol. 29
Open Access | Times Cited: 1
Identification of Oxidative Stress-Related Biomarkers in Diabetic Kidney Disease
Xiaoju Ma, Xiaobo Zhang, Tian Leng, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 2
Xiaoju Ma, Xiaobo Zhang, Tian Leng, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-12
Open Access | Times Cited: 2
Prognostic Implications of Six Altered Genes in Asian Non-Surgical Esophageal Carcinoma Patients Treated with Chemoradiotherapy
Alei Feng, Ning Yang, Ruoying Yu, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 41-51
Open Access | Times Cited: 1
Alei Feng, Ning Yang, Ruoying Yu, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 41-51
Open Access | Times Cited: 1
Clinical and Genomic Analysis of Patients with Short Survival after Surgery for Esophageal Squamous Cell Carcinoma
Lu Gao, Rong-Yun Guo, Hao Lu, et al.
Digestive Diseases (2022) Vol. 41, Iss. 3, pp. 353-361
Closed Access | Times Cited: 1
Lu Gao, Rong-Yun Guo, Hao Lu, et al.
Digestive Diseases (2022) Vol. 41, Iss. 3, pp. 353-361
Closed Access | Times Cited: 1